Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Design and Synthesis of Pyridine-Based Pyrrolo[2,3-<i>d</i>]pyrimidine Analogs as CSF1R Inhibitors: Molecular Hybridization and Scaffold Hopping ApproachSrinivasulu Cherukupalli, Carsten Degenhart, Peter Habenberger, et al.
Molecules (Basel, Switzerland)|June 27, 2025
Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R InhibitorsSrinivasulu Cherukupalli, Jan Eickhoff, Carsten Degenhart, et al.
Chemmedchem|February 23, 2026
An Imidazo[2,1-b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α-Hemolysin by Blocking the Pullout of Its Stem DomainVadim S Korotkov, Peer Lukat, Raffaella Di Lucrezia, et al.
Chemmedchem|August 18, 2022
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K-Ras4b InhibitorsStephan Jeuken, Oleksandr Shkura, Marc Röger, et al.
European Journal of Medicinal Chemistry|December 23, 2023
Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from FlatlandFrithjof Bjørnstad, Simen Havik, Thomas Ihle Aarhus, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrationsCorina Hutterer, Jan Eickhoff, Jens Milbradt, et al.
Chemmedchem|March 8, 2023
A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti-Tuberculosis Properties of Moiramide BIrina Kollmorgen, Nathalie Bachmann, Michael Dal Molin, et al.
Pageof 2